Male osteoporosis and androgenic therapy: from testosterone to SARMs.
about
Preservation and promotion of bone formation in the mandible as a response to a novel calcium-phosphate based biomaterial in mineral deficiency induced low bone mass male versus female ratsLoss of androgen receptor promotes adipogenesis but suppresses osteogenesis in bone marrow stromal cells.Modulating testosterone pathway: a new strategy to tackle male skin aging?Dihydrotestosterone, a robust promoter of osteoblastic proliferation and differentiation: understanding of time-mannered and dose-dependent control of bone forming cells.Prevalence of Osteoporosis in Apparently Healthy Adults above 40 Years of Age in Pune City, India.
P2860
Male osteoporosis and androgenic therapy: from testosterone to SARMs.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Male osteoporosis and androgenic therapy: from testosterone to SARMs.
@ast
Male osteoporosis and androgenic therapy: from testosterone to SARMs.
@en
type
label
Male osteoporosis and androgenic therapy: from testosterone to SARMs.
@ast
Male osteoporosis and androgenic therapy: from testosterone to SARMs.
@en
prefLabel
Male osteoporosis and androgenic therapy: from testosterone to SARMs.
@ast
Male osteoporosis and androgenic therapy: from testosterone to SARMs.
@en
P2860
P1476
Male osteoporosis and androgenic therapy: from testosterone to SARMs
@en
P2093
Alberto Falchetti
Antonio Cilotti
P2860
P304
P577
2009-09-01T00:00:00Z